Pigmented progressive purpuric dermatosishttps://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
Tha Pigmented progressive purpuric dermatosis a’ toirt iomradh air na suidheachaidhean craiceann neo-titching a tha air an comharrachadh le sprèadhadh craiceann purpurach. Tha meud an lesion bho 0.3 gu 1 cm agus mar as trice chithear e anns na h-àiteachan as ìsle. Cuidichidh an t-uachdar cortisone airson tachas fhèin agus a 'leasachadh dath a' chraicinn. Chan eil pigmented progressive purpuric dermatosis ag adhbhrachadh comharran sam bith eile a bharrachd air dath craiceann. Tha na leòintean as trice air na buill as ìsle, ach faodaidh iad tachairt an àite sam bith air a 'bhodhaig, a' gabhail a-steach na làmhan, na gàirdeanan, an torso agus eadhon an amhaich.

làimhseachadh ― OTC Drugs
OTC steroid acainn
#Hydrocortisone ointment
#Hydrocortisone cream
☆ Ann an toraidhean 2022 Stiftung Warentest às a’ Ghearmailt, cha robh sàsachd luchd-cleachdaidh le ModelDerm ach beagan nas ìsle na le co-chomhairlean telemedicine pàighte.
  • Schamberg disease ― fireannach 26-bliadhna le bad de pigmentation asymptomatic agus telangiectasia air a’ chas.
    References Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260 
    NIH
    Tha Pigmented purpuric dermatoses (PPD) nam buidheann de shuidheachaidhean craiceann air an comharrachadh le raointean beaga de dh’ fhuil fon chraiceann mar thoradh air sèid capillary. Mar as trice bidh PPD a’ tòiseachadh mar spotan dearg gu purpaidh a thionndaidheas nas fhaide air adhart gu donn òir fhad ‘s a thèid an hemosiderin ath-ghlacadh.
    Pigmented purpuric dermatoses (PPD) include several skin diseases characterized by multiple petechial hemorrhage as consequence of capillaritis. PPD generally present with red to purple macules that progressively evolve to golden-brown color as the hemosiderin is reabsorbed.
     Schamberg Disease 32809367 
    NIH
    Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis. Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura. It is commonly seen in males and mainly affects the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.
     Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156 
    NIH
    Chaidh fiosrachadh mu euslaintich 113 le PPD a sgrùdadh, a’ toirt a-steach 38 a chaidh tro biopsy craiceann airson an sgrùdaidh seo. B’ e an seòrsa clionaigeach as cumanta galar Schamberg (60. 5%) . B’ e suidheachaidhean eile còmhla ri PPD mòr-fhulangas (15. 8%) , tinneas an t-siùcair (10. 5%) , agus feadhainn eile. Nochd eachdraidh cungaidh-leigheis statins (13. 2%) , luchd-bacadh beta (10. 5%) , agus feadhainn eile. Am measg nam factaran a dh’ fhaodadh a bhith co-cheangailte ri PPD bha galar analach àrd o chionn ghoirid (5. 3%) , seasamh fada a’ leantainn gu cuideam àrd orthostatic (2. 6%) , agus eacarsaich dian (2. 6%) . Chaidh làimhseachadh a thoirt do 36 euslaintich (94. 7%) - oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
    Information on 113 patients with PPD was analyzed, and 38 subjects with skin biopsy were included for this study. Schamberg's disease was the most frequent clinical type (60.5%). Concomitant diseases included hypertension (15.8%), diabetes (10.5%), and others. Associated medication histories included statins (13.2%), beta blockers (10.5%), and others. Possibly associated etiologic factors were recent upper respiratory infection (5.3%), high orthostatic pressure due to prolonged standing (2.6%), and strenuous exercise (2.6%). A total of 36 patients (94.7%) were treated with one or more treatment methods, including oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.